Literature DB >> 17221865

MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified.

Rosa Ferrentino1, Maria Teresa Bassi, David Chitayat, Elisabetta Tabolacci, Germana Meroni.   

Abstract

Opitz G/BBB Syndrome (OS) is a multiple congenital anomaly disorder characterized by defects along the body midline. The disease is characterized by variable expressivity of signs that include hypertelorism, cleft lip and/or palate, laryngo-tracheo-esophageal abnormalities, cardiac defects, and hypospadias. OS patients also present with mental retardation and brain anatomical abnormalities. An autosomal dominant form mapping to chromosome 22 and an X-linked form of OS are known. The gene responsible for the X-linked form of OS, MID1, codes for a member of the Tripartite Motif family of E3 ubiquitin ligases. Here we report 29 novel mutations in 29 unrelated patients of a cohort of 140 male OS cases. These mutations are found in both familial and sporadic cases. They are scattered along the entire length of the gene and are represented by missense and nonsense mutations, insertions and deletions causing frame shift mutations, and deletion of either single exons or the entire gene. The variety of the mutations found confirms that loss-of-function is the mechanism underlying the OS phenotype. Moreover, the low percentage of MID1-mutated OS patients, 47% of the familial and 13% of the sporadic cases, suggests a wider genetic heterogeneity underlying the OS phenotype. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221865     DOI: 10.1002/humu.9480

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

Review 1.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

2.  TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved.

Authors:  Anthony H Keeble; Zahra Khan; Alan Forster; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

Review 3.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

4.  Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome.

Authors:  Nuno Maia; Maria J Nabais Sá; Nataliya Tkachenko; Gabriela Soares; Isabel Marques; Bárbara Rodrigues; Ana M Fortuna; Rosário Santos; Arjan P M de Brouwer; Paula Jorge
Journal:  Mol Syndromol       Date:  2017-08-29

5.  Phenotypic spectrum associated with SPECC1L pathogenic variants: new families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes.

Authors:  Elizabeth J Bhoj; Damien Haye; Annick Toutain; Dominique Bonneau; Irene Kibæk Nielsen; Ida Bay Lund; Pauline Bogaard; Stine Leenskjold; Kadri Karaer; Katherine T Wild; Katheryn L Grand; Mirena C Astiazaran; Luis A Gonzalez-Nieto; Ana Carvalho; Daphné Lehalle; Shivarajan M Amudhavalli; Elena Repnikova; Carol Saunders; Isabelle Thiffault; Irfan Saadi; Dong Li; Hakon Hakonarson; Yoann Vial; Elaine Zackai; Patrick Callier; Séverine Drunat; Alain Verloes
Journal:  Eur J Med Genet       Date:  2018-11-22       Impact factor: 2.465

6.  Molecular dynamics simulation reveals insights into the mechanism of unfolding by the A130T/V mutations within the MID1 zinc-binding Bbox1 domain.

Authors:  Yunjie Zhao; Chen Zeng; Michael A Massiah
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  The Challenge of Prenatal Diagnostic Work-Up of Maternally Inherited X-Linked Opitz G/BBB: Case Report and Literature Review.

Authors:  Marialuigia Spinelli; Carmine Sica; Bruno Dallapiccola; Antonio Novelli; Letizia Di Meglio; Pasquale Martinelli
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-04

8.  Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.

Authors:  Beatriz Aranda-Orgillés; Johanna Aigner; Melanie Kunath; Rudi Lurz; Rainer Schneider; Susann Schweiger
Journal:  PLoS One       Date:  2008-10-24       Impact factor: 3.240

9.  XLOS-observed mutations of MID1 Bbox1 domain cause domain unfolding.

Authors:  Katharine M Wright; Kuanlin Wu; Omotolani Babatunde; Haijuan Du; Michael A Massiah
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.

Authors:  Haijuan Du; Kuanlin Wu; Alma Didoronkute; Marcus V A Levy; Nimish Todi; Anna Shchelokova; Michael A Massiah
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.